GBA1 and Parkinson disease: Mutations in the GBA gene, which is crucial for ceramide metabolism, result in more severe cognitive dysfunction in PD patients [35, 36], likely due to reduced glucocerebrosidase (GCase) activity, which disrupts the ceramide balance and facilitates α‐synuclein accumulation in neurons [37, 38, 39].